HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-benzyl-4-[(1-cyclohexyl-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]piperidin-4-ol → 4-[(1-cyclohexyl-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]piperidin-4-ol
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-benzyl-4-[(1-cyclohexyl-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]piperidin-4-ol | HCID 59396561 | — |
| Catalyst | Palladium hydroxide | HCID 9942167 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | 4-[(1-cyclohexyl-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]piperidin-4-ol | HCID 59396410 | 88.4% |
Reaction Steps
1-benzyl-4-[(1-cyclohexyl-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]piperidin-4-ol (220 mg) was dissolved in MeOH (12 mL), and 20% palladium hydroxide-supported activated carbon (360 mg) was added thereto, followed by stirring under a hydrogen atmosphere, at room temperature and normal pressure, for 15 hours. Thereafter, the catalyst was separated through celite. The solvent was evaporated to obtain 4-[(1-cyclohexyl-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]piperidin-4-ol (154 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08263607B2 |
| Source dataset | uspto-grants-2012_09 |
| ORD ID | ord-8883bac642cf4bc68aff489c7a6ff4c4 |
| Source note | uspto-grants-2012_09 |